GlassScriptPhysician profile
Ashley Uvanni
NPI 1629637897
$1,077.72
in general payments reported to CMS, 2019-2025
18 companies · $241 in 2025
The $241 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $81.25 · 2023: $270 · 2024: $486 · 2025: $241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $911 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $911.48 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $239.49 | 2024-2025 | Veozah |
| Medtronic, INC. | $147.89 | 2023-2024 | Interstim, V-Loc 180 |
| Exeltis, USA INC. | $115.49 | 2024-2025 | Slynd |
| Coloplast Corp | $97.84 | 2023 | Altis |
| Boston Scientific Corporation | $81.25 | 2022 | |
| Biogen, INC. | $56.42 | 2025 | Zurzuvae |
| Optumhealth Care Solutions, LLC | $51.54 | 2023 | Zyno Solutions, Vivify Health Care Team Portal |
| Mayne Pharma Commercial LLC | $40.07 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $37.93 | 2025 | |
| Mimedx Group, INC. | $34.49 | 2024 | |
| Millicent US INC | $30.19 | 2025 | Femring, Intrarosa, Femlyv |
| Lilly USA, LLC | $28.56 | 2024 | Zepbound |
| Sumitomo Pharma America, INC. | $23.71 | 2024 | Gemtesa |
| Coopersurgical, INC. | $22.11 | 2024 | Paragard T 380a |
| Astellas Pharma Global Development | $22.06 | 2024 | Veozah |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $17.69 | 2023 | |
| Merck Sharp & Dohme LLC | $16.07 | 2024 | Gardasil, Gardasil 9 |
| Shield Therapeutics INC | $14.92 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Uvanni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.